Related Experiment Video
Updated: Mar 5, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Imazamethabenz inhibits human breast cancer cell proliferation, migration and invasion via combination with Pin1
Chen Liu1, Chaoyu Mu1, Zeng Li1
1College of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Abstract:
Overexpression of peptidyl-prolyl cis/trans isomerase, NIMA interacting‑1 (Pin1) is a significant marker of the occurrence and development of tumors. In the present study, the imidazoline ketone herbicide imazamethabenz was investigated as a potential antitumor drug by inhibiting Pin1. Molecular docking and enzyme activity tests verified, for the first time, that the imidazoline ketone compound imazamethabenz effectively inhibited Pin1 in vitro. MTT assays, western blotting, wound healing assay and Matrigel invasion assays revealed that imazamethabenz induced apoptosis and inhibited migration and invasion of the breast cancer cell line MCF‑7, which overexpresses Pin1, by inhibiting the Pin1‑mediated signaling pathway involving vascular endothelial growth factor and matrix metalloproteinase 9. These findings indicated that imazamethabenz offers potential applications for the treatment of tumors as a Pin1 inhibitor.
Insights
The herbicide imazamethabenz inhibits peptidyl-prolyl cis/trans isomerase, NIMA interacting‑1 (Pin1), a key marker in tumor development. This compound shows potential as an antitumor drug by inducing apoptosis and inhibiting breast cancer cell migration and invasion.
Area of Science:
- Biochemistry
- Oncology
- Drug Discovery
Background:
- Overexpression of peptidyl-prolyl cis/trans isomerase, NIMA interacting‑1 (Pin1) is linked to tumor occurrence and progression.
- Pin1 plays a crucial role in cancer cell signaling pathways.
Purpose of the Study:
- To investigate the potential of the herbicide imazamethabenz as an antitumor agent by targeting Pin1.
- To elucidate the mechanism by which imazamethabenz affects cancer cells.
Main Methods:
- Molecular docking and in vitro enzyme activity assays to confirm Pin1 inhibition.
- MTT assays, western blotting, wound healing, and Matrigel invasion assays on MCF-7 breast cancer cells.
Main Results:
- Imazamethabenz was confirmed to effectively inhibit Pin1 in vitro.
- The compound induced apoptosis and suppressed migration and invasion in MCF-7 cells.
- Inhibition of Pin1-mediated signaling pathways involving VEGF and MMP-9 was observed.
Conclusions:
- Imazamethabenz demonstrates significant antitumor potential by inhibiting Pin1.
- This herbicide offers a novel therapeutic strategy for treating Pin1-overexpressing tumors.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

